Iris D. Gersten

1.0k total citations
10 papers, 510 citations indexed

About

Iris D. Gersten is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Iris D. Gersten has authored 10 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Iris D. Gersten's work include Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Iris D. Gersten is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Iris D. Gersten collaborates with scholars based in United States and South Africa. Iris D. Gersten's co-authors include Dennis L. Confer, Shelly L. Carter, John R. Wingard, Lindsey R. Baden, Thomas J. Walsh, Kieren A. Marr, Javier Bolaños‐Meade, Helen Leather, Richard T. Maziarz and John F. DiPersio and has published in prestigious journals such as Blood, Biology of Blood and Marrow Transplantation and American Journal of Health-System Pharmacy.

In The Last Decade

Iris D. Gersten

10 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris D. Gersten United States	7	345	326	173	97	55	10	510
Stefan Neuburger Germany	11	145 0.4×	176 0.5×	138 0.8×	163 1.7×	84 1.5×	14	502
Cornelia Becker Germany	7	203 0.6×	197 0.6×	56 0.3×	83 0.9×	59 1.1×	33	412
Clara Minotti Italy	13	104 0.3×	142 0.4×	160 0.9×	199 2.1×	108 2.0×	35	490
Jenna Rossoff United States	8	67 0.2×	113 0.3×	68 0.4×	43 0.4×	36 0.7×	20	283
Per Ljungman Sweden	5	249 0.7×	388 1.2×	159 0.9×	72 0.7×	19 0.3×	5	484
P. M. Flynn United States	6	196 0.6×	223 0.7×	167 1.0×	35 0.4×	41 0.7×	8	408
Kamonwan Jutivorakool Thailand	10	260 0.8×	377 1.2×	70 0.4×	19 0.2×	13 0.2×	21	602
Maria Licciardello Italy	11	86 0.2×	108 0.3×	125 0.7×	72 0.7×	28 0.5×	20	367
Hubert Szelényi Germany	8	139 0.4×	162 0.5×	139 0.8×	28 0.3×	24 0.4×	23	320
Elizabeth H. Perry United States	15	100 0.3×	59 0.2×	111 0.6×	266 2.7×	84 1.5×	21	611

Countries citing papers authored by Iris D. Gersten

Since Specialization

Citations

This map shows the geographic impact of Iris D. Gersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris D. Gersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris D. Gersten more than expected).

Fields of papers citing papers by Iris D. Gersten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris D. Gersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris D. Gersten. The network helps show where Iris D. Gersten may publish in the future.

Co-authorship network of co-authors of Iris D. Gersten

This figure shows the co-authorship network connecting the top 25 collaborators of Iris D. Gersten. A scholar is included among the top collaborators of Iris D. Gersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris D. Gersten. Iris D. Gersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Spellecy, Ryan, Sergey Tarima, Ellen M. Denzen, et al.. (2018). Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study. Biology of Blood and Marrow Transplantation. 24(10). 2145–2151. 13 indexed citations

Laport, Ginna G., Juan Wu, Brent R. Logan, et al.. (2016). Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network. Biology of Blood and Marrow Transplantation. 22(8). 1440–1448. 37 indexed citations

Shenoy, Shalini, Mary Eapen, Juan Wu, et al.. (2016). Results of the Blood and Marrow Transplant Clinical Trials Network Study BMT CTN 0601: Scurt - a Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation (BMT) for Children with Severe Sickle Cell Disease. Biology of Blood and Marrow Transplantation. 22(3). S104–S104. 2 indexed citations

Shenoy, Shalini, Mary Eapen, Juan Wu, et al.. (2015). A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study. Blood. 126(23). 619–619. 6 indexed citations

Laport, Ginna G., Juan Wu, Brent R. Logan, et al.. (2014). Reduced Intensity Conditioning (RIC) with Rituximab Yields Excellent Outcomes after Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Relapsed Follicuar Lymphoma (FL): A Phase II Multicenter Trial from the Blood and Marrow Transplant Network (BMT CTN 0701). Blood. 124(21). 682–682. 2 indexed citations

Mauskopf, Josephine, Costel Chirila, James E. Graham, et al.. (2013). Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. American Journal of Health-System Pharmacy. 70(17). 1518–1527. 13 indexed citations

Tolar, Jakub, H. Joachim Deeg, Sally Arai, et al.. (2012). Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels. Biology of Blood and Marrow Transplantation. 18(7). 1007–1011. 35 indexed citations

Denzen, Ellen M., Heather Moore, Amy Foley, et al.. (2011). Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials. Biology of Blood and Marrow Transplantation. 18(2). 183–189. 25 indexed citations

Wingard, John R., Shelly L. Carter, Thomas J. Walsh, et al.. (2010). Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 116(24). 5111–5118. 316 indexed citations

10.

Wingard, John R., Shelly L. Carter, Thomas J. Walsh, et al.. (2007). Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.. Blood. 110(11). 163–163. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact